dQ&A Prescriber Perspectives
dQ&A Prescriber Perspectives is detailed primary research from over n=1,300 prescribers in the USA, Canada and EU 5 (UK, Germany, France, Spain, Italy) conducted between March and August 2026.The data is extensive and yields many insights for diabetes manufacturers. It is available at a fraction of the price of performing the research yourself.
Case Studies
Below, we have two overlapping case studies on the relationship between GLP-1 and insulin.
EU Prescribers: GLP-1s are changing insulin’s timetable, but not displacing it(n=684)
US Prescribers: Will GLP-1s replace insulin? - Yes and No(n=700 and US Patients n=2,491)
For more information about Prescriber Perspectives:
Do You Have Questions
About Diabetes Research?
We Have Answers.
This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.
